ChIP-Seq from $1,300/Assay

Up to 25% off for a limited time — sequencing and data processing included

  • Quantitative, antibody-based chromatin profiling
  • Standard turnaround available
  • Use code CSP2026
Request a Quote

Transcription Factor Profiling Across ChIP, CUT&Run, and CUT&Tag

We profile transcription factors across ChIP, CUT&Run, and CUT&Tag and guide assay selection based on target biology, antibody performance, input constraints, and failure risk. The goal is high-confidence quantitative and de-noised occupancy data with practical next-step recommendations.

3 Bulk Modalities

ChIP for TF Binding

CUT&Tag Ready

Talk to a Scientist Explore Bulk Epigenetic Services Request a Quote

Method Selection for TF Programs

One target, multiple valid assay paths

No single assay is universally best for every TF project. We evaluate target abundance, antibody behavior, sample input, and acceptable background model before selecting ChIP, CUT&Run, or CUT&Tag.

Selection Inputs

  • Target abundance and expected occupancy strength
  • Antibody affinity and validation status
  • Input material and replicate scope
  • Required confidence level for downstream decisions

Decision matrix mapping assay constraints to ChIP, CUT&Run, and CUT&Tag
Assay selection is anchored to target biology and project constraints, not one-size-fits-all preference.
Method Strengths Main Drawbacks Typical Fit
ChIP Gold-standard TF occupancy with conservative interpretation Higher input burden, deeper sequencing, per-assay control requirements Benchmark occupancy and legacy comparability
CUT&Tag Lower input and sequencing burden, focused enrichment Open-chromatin-like background can confound interpretation without controls Input-limited or throughput-sensitive TF programs
CUT&Run Lower input than ChIP in many settings Strongly target- and antibody-dependent with potential background inflation Bulk projects with suitable target-antibody performance

ChIP: Reference Method for TF Occupancy

Gold-standard occupancy interpretation

ChIP remains the reference method for TF binding questions requiring conservative interpretation and broad comparability to legacy datasets.

Planning Constraints

  • Often around 1M cells per assay in TF settings
  • Crosslinking/fixation can affect epitope accessibility
  • TF ChIP commonly requires deeper sequencing
  • Per-assay IgG/background controls are standard

ChIP TF browser tracks across representative factors and loci
ChIP provides benchmark occupancy maps when input, controls, and sequencing depth are properly scoped.

Quantitative/QC Standard

ChIP includes exogenous spike-in chromatin from a second species (typically D. melanogaster) paired with an antibody against a spike-in-species-specific target. Spike-in behavior supports both cross-condition normalization and technical QC across pulldown, library prep, and sequencing depth.

CUT&Tag: Lower-Input TF Profiling

High-enrichment profiling with practical inputs

CUT&Tag commonly lowers input and sequencing requirements while producing concentrated peak signal for TF studies.

Operational Advantages

  • Lower input requirements than ChIP
  • Lower sequencing requirements in many projects
  • Crosslinking often not required
  • Higher fragments-in-peaks is commonly observed

DeepTools heatmaps comparing TF enrichment in ChIP versus CUT&Tag
CUT&Tag often yields concentrated peak signal with reduced background relative to ChIP.

Interpretation and Quantitative/QC Standards

TF CUT&Tag background can resemble open chromatin. IgG/background controls, replicate concordance, and biologically anchored interpretation are standard. CUT&Tag includes spike-in nuclei rather than purified chromatin so the reference material follows the same nuclei handling and tagmentation workflow, improving both quantitative comparability and assay QC.

CUT&Run: Target-Dependent Performance

Lower-input path with target-dependent risk

CUT&Run can perform strongly in suitable systems, but target abundance and antibody quality affect both digestion and pulldown outcomes.

Key Limits

  • Low-abundance targets can reduce effective signal
  • Lower-affinity antibodies can elevate background
  • Pilot data often determines final assay fit

CUT&Run examples illustrating strong versus weak target performance
CUT&Run outcomes are strongly conditioned by target abundance and antibody behavior.

Quantitative/QC Standard

CUT&Run uses the same spike-in framework as ChIP: second-species chromatin (commonly D. melanogaster) with a species-specific antibody target. Spike-in recovery is used for normalization and as a QC indicator across digestion, pulldown, and library generation.

Single-Cell TF Profiling Feasibility

Single-cell CUT&Tag and Paired-Tag for qualified targets

Single-cell TF assays are most reliable when target abundance is sufficient within each biologically relevant population. As a practical rule-of-thumb, targets near or above approximately 50,000 copies per cell are more likely to yield interpretable signal.

Feasibility Checks

  • Target abundance in each constituent cell population
  • Antibody performance in low-copy contexts
  • Pilot success criteria defined before scale-up

Single-cell TF occupancy by cluster with pseudo-bulk track context
Single-cell TF interpretation depends on target abundance across constituent cell types, not only sample-level abundance.

Recommended Engagement Pattern

  1. Feasibility Review

    Assess target abundance, antibody constraints, and cell-population composition.

  2. Assay Selection

    Select bulk or single-cell entry path based on interpretive risk and input constraints.

  3. Execution

    Run with assay-appropriate controls and spike-in/QC standards.

  4. Scientist Handoff

    Deliver interpretation anchored to assay-specific considerations and next-step recommendations.

Choose the Right TF Assay Before You Commit Samples

Start with a scientist review of your target, antibody, and sample constraints. We recommend the assay with the best balance of confidence, input feasibility, and sequencing burden for your project.

Talk to a Scientist Explore Bulk Epigenetic Services Request a Quote